In this podcast, Stephenson Harwood corporate finance partners, Tom Page and Kristian Shearsby, are joined by Vadim Alexandre, Head of Healthcare, and Matthew Johnson, Director of Corporate Finance, at SP Angel to discuss what they are seeing in the market including:

• Trends in the public markets for the life sciences sector – is there more to the story and where are the green shoots?
• Top tips for IPO listing – what you can do to take maximum advantage of an IPO window? 
• AI – is it delivering?
• Secondary market – are things improving?
• Will M&A increase in 2023? 
• AIM vs NASDAQ

Welcome to our podcast discussing the UK's new National Security and Investment Act 2021 ("NSIA") and its impact on the life sciences sector. In this podcast, our expert panel discusses the key implications of the NSIA for companies active in life sciences, highlighting the main areas that need to be considered and providing practical tips.